Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Venturini, A."'
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 17
In primary breast cancer, taxane-based compared with anthracycline-based adjuvant chemotherapy significantly reduces the relative risk of recurrence (ranging from 17% to 36%) and sometimes improves overall survival. Different dosages and schedules of
Autor:
Riccardo Rosso, L. Del Mastro, M. Venturini, C. Bighin, Lucia Fratino, Antonella Venturino, Luigi Manzione, Lazzaro Repetto, Vittorina Zagonel, T. Catzeddu, F. Perrone, E. Maggi, D. Marenco
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 16(2)
Background First-line chemotherapy regimens suitable for elderly advanced breast cancer patients are still not defined. Patients and methods Women with stage III or IV breast cancer aged ≥70 years were enrolled in a phase II study aimed to evaluate
Autor:
Paola Papaldo, S. Donati, M. Bergaglio, C. Sguotti, R. Rosso, Gianluigi Lunardi, L. Frevola, Francesco Cognetti, M. Venturini, L. Del Mastro, R. Lionetto, Andrea Michelotti
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 12(8)
Summary Purpose: To determine the maximum tolerated dose (MTD) and the dose limiting toxicity (DLT) of docetaxel in combination with fixed doses of epirubicin. Patients and methods: Women with locally advanced or metastatic breast cancer were given d
Autor:
C. Viscoli, C. Bighin, G. Pietra, Giovanni Melioli, M. Bergaglio, C. Semino, Mario Roberto Sertoli, Riccardo Rosso, L. Del Mastro, M. Venturini, A. Signorini, A. Lambiase, G. Bertelli, Sergio Bertoglio
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 12(4)
Summary Background The majority of high-dose chemotherapy (HDC)-related complications results from bone marrow aplasia, but the graft infusion per se may cause adverse reactions due to the injection of both dimethyl sulfoxide (DMSO) and cell lysis pr
Autor:
Marina Guenzi, I. Stevani, L. Del Mastro, P. Ricci, M. Venturini, G. Sanguineti, M. Cavallari, G. Canavese
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 12(3)
To evaluate if chemotherapy (CT) dose-intensification jeopardizes radiotherapy (RT) dose-intensity (DI).From 1992 to 1997, 247 stage I-II breast cancer patients, treated with conserving surgery, were treated at the National Cancer Institute of Genoa